TRIB trinitybiotech.com Expected Profit

The market split of Trinity Biotech plc (TRIB) is based on strict FDA/CE standards and contracts that create a robust defensive moat. Examining the prospective profit chart on GURU.Markets reveals a growth vector where 0.01 shows the current volume of the metric. Stable pricing is ensured by confidence in diabetes and HIV tests, while the environmental vector is implemented through plastic minimization and the reduction of the carbon footprint.

TRIB - Trinity Biotech Corp Expected Net Profit over the range 07/04/2022 - 10/04/2023

TRIB (Trinity Biotech): analytical breakdowns and indicator data

- share price and consensus valuation forecast:

Stock Price Trinity Biotech PLC|TRIB - Analyst Consensus Forecast

- market capitalization data:

Market Value Trinity Biotech|TRIB - Total Company Value

- company book value details:

Accounting Value per Share Trinity Biotech|TRIB - Total Stockholders' Equity|Market Value to Book Value Ratio trinitybiotech.com|TRIB - Company Total Asset Base

- debt and solvency information:

- earnings and market ratios statistics:

TRIB - Net Financial Result|Expected Profit Trinity Biotech plc|TRIB - Price to Earnings Multiple|Forward P/E Multiple Trinity Biotech PLC|TRIB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Trinity Biotech|TRIB - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Trinity Biotech|TRIB - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months trinitybiotech.com|TRIB - Earnings per share increase in current year|Earnings growth forecast for next year Trinity Biotech plc

Initial company analysis:Trinity Biotech plc

Finished products of Trinity Biotech PLC

This indicator reflects the discounted value of the company's expected net income, allowing for an assessment of the business's fundamental value through the lens of future cash flows. For Trinity Biotech plc (TRIB), the effectiveness of this model depends directly on the optimization of costs related to contract electronics manufacturing and global logistics. By analyzing the projected cash result, an investor can observe the dynamics of capital flow between assets. However, growth in indicators does not eliminate risks during a systemic liquidity shortage. A stable trend confirms the resilience of the company's operating model.

Direct competitors